Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16207203 | 1.00 | ALOX5 (0.36) | ALOX5CNR2ALDH1A1 | |
| SCHEMBL15959620 | 0.92 | ALOX5 (0.42) | ALOX5ALDH1A1 | |
| SCHEMBL16207212 | 0.87 | ALOX5 (0.40) | ALOX5CNR2ALDH1A1 | |
| SCHEMBL25284649 | 0.86 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL20991379 | 0.86 | ALOX5 (0.42) | ALOX5ALDH1A1 | |
| SCHEMBL16207204 | 0.83 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL16207202 | 0.79 | ALOX5 (0.44) | ALOX5CNR2ALDH1A1 | |
| SCHEMBL14546126 | 0.79 | ALOX5 (0.48) | ALOX5CNR2ALDH1A1 | |
| SCHEMBL15259591 | 0.79 | ALOX5 (0.55) | ALOX5ALDH1A1 | |
| SCHEMBL15259595 | 0.79 | ALOX5 (0.55) | ALOX5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9163032-B2 | Esters of DCPLA and methods of treatment using the same | Blanchette Rockefeller Neurosciences Insitute (US) | 2015-10-20 | — | — | US | disclosed |
| US-9163032-B2 | Esters of DCPLA and methods of treatment using the same | Blanchette Rockefeller Neurosciences Insitute (US) | 2015-10-20 | — | — | US | disclosed |
| US-20140323456-A1 | ESTERS OF DCPLA AND METHODS OF TREATMENT USING THE SAME | COGNITIVE RESEARCH ENTERPRISES, INC. | 2014-10-30 | — | — | US | disclosed |
| US-20140323456-A1 | ESTERS OF DCPLA AND METHODS OF TREATMENT USING THE SAME | COGNITIVE RESEARCH ENTERPRISES, INC. | 2014-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323456-A1 | ESTERS OF DCPLA AND METHODS OF TREATMENT USING THE SAME | LIPA, PCCA, PNLIP | ALOX5 130/4885CNR2 2821/4885ALDH1A1 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.